Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years

Cancer treatment has been greatly improved by the combined use of targeted therapies and novel biotechnological methods. Regarding the former, pegylated liposomal doxorubicin (PLD) has a preferential accumulation within cancer tumors, thus having lower toxicity on healthy cells. PLD has been impleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Filip, Stanislav, Kubeček, Ondřej, Špaček, Jiří, Lánská, Miriam, Bláha, Milan, Martínková, Jiřina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600532/
https://www.ncbi.nlm.nih.gov/pubmed/33008072
http://dx.doi.org/10.3390/pharmaceutics12100940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600532/
https://www.ncbi.nlm.nih.gov/pubmed/33008072
http://dx.doi.org/10.3390/pharmaceutics12100940

Ejemplares similares